이 페이지를 로드하는 동안 오류가 발생한 것 같습니다.
지원팀에 전달되었습니다. 만약 문제가 지속될 경우 이메일 지원 위젯을 통해 다시 문의 부탁드립니다.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Revenue Multiple | 4.3x - 4.7x | 4.5x |
| Selected Fwd Revenue Multiple | 3.3x - 3.6x | 3.5x |
| Fair Value | ﷼136.92 - ﷼151.90 | ﷼144.41 |
| Upside | 12.0% - 24.3% | 18.2% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Al Hammadi Holding Company | 4007 | SASE:4007 |
| Mouwasat Medical Services Company | 4002 | SASE:4002 |
| Dr. Sulaiman Al Habib Medical Services Group Company | 4013 | SASE:4013 |
| Almoosa Health Company | 4018 | SASE:4018 |
| National Medical Care Company | 4005 | SASE:4005 |
| Dallah Healthcare Company | 4004 | SASE:4004 |
| Select LTM Revenue Multiple | ||||||||
| Benchmark Companies | ||||||||
| 4007 | 4002 | 4013 | 4018 | 4005 | 4004 | |||
| SASE:4007 | SASE:4002 | SASE:4013 | SASE:4018 | SASE:4005 | SASE:4004 | |||
| Historical Revenue Growth | ||||||||
| 5Y CAGR | 3.4% | 9.2% | 17.4% | NM- | 12.8% | 20.7% | ||
| 3Y CAGR | 6.6% | 10.3% | 15.6% | 19.7% | 15.2% | 15.0% | ||
| Latest Twelve Months | -1.9% | 6.4% | 17.8% | 22.8% | 19.6% | 8.9% | ||
| Historical EBIT Profit Margin | ||||||||
| 5 Year Average Margin | 21.3% | 27.9% | 20.3% | 12.2% | 19.2% | 15.9% | ||
| Prior Fiscal Year | 29.1% | 28.0% | 22.0% | 12.7% | 22.8% | 17.2% | ||
| Latest Fiscal Year | 26.5% | 25.1% | 21.0% | 15.1% | 19.7% | 17.7% | ||
| Latest Twelve Months | 26.5% | 25.1% | 21.0% | 15.1% | 19.7% | 17.7% | ||
| Current Trading Multiples | ||||||||
| EV / LTM Revenue | 5.59x | 5.19x | 9.03x | 6.58x | 5.24x | 3.93x | ||
| EV / LTM EBIT | 21.1x | 20.6x | 42.9x | 43.5x | 26.6x | 22.2x | ||
| Price / LTM Sales | 5.66x | 5.05x | 8.52x | 5.49x | 5.30x | 3.77x | ||
| Low | Mid | High | ||||||
| Benchmark EV / LTM Revenue | 5.19x | 5.59x | 9.03x | |||||
| Historical EV / LTM Revenue | 3.93x | 4.20x | 6.22x | |||||
| Selected EV / LTM Revenue | 4.25x | 4.48x | 4.70x | |||||
| (x) LTM Revenue | 3,206 | 3,206 | 3,206 | |||||
| (=) Implied Enterprise Value | 13,638 | 14,355 | 15,073 | |||||
| (-) Non-shareholder Claims * | (528) | (528) | (528) | |||||
| (=) Equity Value | 13,109 | 13,827 | 14,545 | |||||
| (/) Shares Outstanding | 97.3 | 97.3 | 97.3 | |||||
| Implied Value Range | 134.72 | 142.10 | 149.48 | |||||
| FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 134.72 | 142.10 | 149.48 | 122.20 | ||||
| Upside / (Downside) | 10.2% | 16.3% | 22.3% | |||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4007 | 4002 | 4013 | 4018 | 4005 | 4004 | |
| Enterprise Value | 6,452 | 14,935 | 100,447 | 7,828 | 6,756 | 12,419 | |
| (+) Cash & Short Term Investments | 245 | 512 | 2,891 | 38 | 567 | 166 | |
| (+) Investments & Other | 135 | 0 | 465 | 9 | 0 | 1,607 | |
| (-) Debt | (304) | (762) | (8,165) | (1,353) | (488) | (2,023) | |
| (-) Other Liabilities | 0 | (145) | (438) | 0 | 0 | (278) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 6,528 | 14,540 | 95,200 | 6,521 | 6,835 | 11,891 | |
| (/) Shares Outstanding | 160.0 | 200.0 | 350.0 | 44.3 | 44.9 | 97.3 | |
| Implied Stock Price | 40.80 | 72.70 | 272.00 | 147.20 | 152.40 | 122.20 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 40.80 | 72.70 | 272.00 | 147.20 | 152.40 | 122.20 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |